Literature DB >> 2987533

The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes.

R R Spaete, E S Mocarski.   

Abstract

Although herpes simplex virus (HSV) 1 and human cytomegalovirus (CMV) differ remarkably in their biological characteristics and do not share nucleotide sequence homology, they have in common a genome structure that undergoes sequence isomerization of the long (L) and short (S) components. We have demonstrated that the similarity in their genome structures extends to the existence of an alpha sequence in the CMV genome as previously defined for the HSV genome. As such, the alpha sequence is predicted to participate as a cis-replication signal in four viral functions: (i) inversion, (ii) circularization, (iii) amplification, and (iv) cleavage and packaging of progeny viral DNA. We have constructed a chimeric HSV-CMV amplicon (herpesvirus cis replication functions carried on an Escherichia coli plasmid vector) substituting CMV DNA sequences for the HSV cleavage/packaging signal in a test of the ability of this CMV L-S junction sequence to provide the cis signal for cleavage/packaging in HSV 1-infected cells. We demonstrate that the alpha sequence of CMV DNA functions as a cleavage/packaging signal for HSV defective genomes. We show the structure of this sequence and provide a functional demonstration of cross complementation in replication signals which have been preserved over evolutionary time in these two widely divergent human herpesviruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987533      PMCID: PMC254869     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Plasmid pKC7: a vector containing ten restriction endonuclease sites suitable for cloning DNA segments.

Authors:  R N Rao; S G Rogers
Journal:  Gene       Date:  1979-09       Impact factor: 3.688

2.  Structure and origin of defective genomes contained in serially passaged herpes simplex virus type 1 (Justin).

Authors:  H Locker; N Frenkel
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

3.  DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage.

Authors:  M F Stinski; E S Mocarski; D R Thomsen
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

4.  The herpes simplex virus amplicon: analyses of cis-acting replication functions.

Authors:  R R Spaete; N Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions.

Authors:  E S Mocarski; L E Post; B Roizman
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

6.  Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments.

Authors:  L E Post; A J Conley; E S Mocarski; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  BamI, KpnI, and SalI restriction enzyme maps of the DNAs of herpes simplex virus strains Justin and F: occurrence of heterogeneities in defined regions of the viral DNA.

Authors:  H Locker; N Frenkel
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

10.  Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides.

Authors:  A J Conley; D M Knipe; P C Jones; B Roizman
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  45 in total

1.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Rapid epidemiologic analysis of cytomegalovirus by using polymerase chain reaction amplification of the L-S junction region.

Authors:  D M Sokol; G J Demmler; G J Buffone
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family.

Authors:  T R Jones; V P Muzithras
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  A human cytomegalovirus function inhibits replication of herpes simplex virus.

Authors:  K D Cockley; K Shiraki; F Rapp
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Translational control of human cytomegalovirus gp48 expression.

Authors:  M R Schleiss; C R Degnin; A P Geballe
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter.

Authors:  D X Zhou; T S Yen
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

7.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.

Authors:  K Kondo; J Xu; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 8.  Recent progress in cytomegalovirus research.

Authors:  J D Benson; E S Huang
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

9.  A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence.

Authors:  G W Kemble; E S Mocarski
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.